Abstract C084: The farnesyl transferase inhibitor KO-2806 constrains mTORC1 activity to enhance the antitumor efficacy of mutant-selective PI3Kα inhibitors
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Institution: Kura Oncology (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4415444890
Cites:
Cited by:
Related to:
